GleamWall
中文EN

PLSM Pulsenmore Ltd. IFRS Annual reports only

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 2064764 · Reporting currency ILS · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY314.3%
TTM net income YoY56.8%
TTM EPS YoY-57.3%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin84.2%
Operating margin—
Net margin-39.6%
FCF margin-82.5%
EBITDA margin—

Returns

ROE-17.6%
ROA-13.0%
ROIC (approx.)—
Asset turnover0.33x

Leverage & solvency

Liabilities / assets18.4%
Debt / equity0.00x
Current ratio7.88x
Interest coverage—

Cash quality & payout

Operating cash flow / net income2.07x
Accruals ratio14.0%
Payout ratio—
Capex / revenue0.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: ILS FY2025*2025-12-31FY2024*2024-12-31
Income statement
Revenue40.02M9.66M
Cost of revenue6.34M6.08M
Gross profit33.68M3.58M
R&D expense17.35M20.13M
SG&A expense16.68M15.34M
Interest expense7.22M540,000
Pretax income-15.85M-36.79M
Income tax1,000-56,000
Net income-15.85M-36.74M
EPS (basic)2.465.76
EPS (diluted)2.465.76
Balance sheet
Cash & equivalents21.60M41.17M
Receivables4.14M3.91M
Inventory19.93M23.09M
Current assets81.40M132.40M
PP&E, netmay include right-of-use assets (IFRS)5.82M7.64M
Total assets101.85M141.83M
Current liabilities10.33M14.26M
Total liabilities18.76M44.94M
Shareholders' equity83.09M96.89M
Cash flow statement
Operating cash flow-32.88M-41.46M
Capital expenditure135,000509,000
Free cash flow-33.01M-41.97M
Investing cash flow13.85M58.58M
Financing cash flow4,000-1.56M
Depreciation & amortization2.80M2.85M
Stock-based compensation667,0001.39M

Free plan shows the latest 2 periods; Pro shows all 3 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· Amounts are in the company's reporting currency, ILS, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.